These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study]. Brügmann U; Blasini R; Rudolph W Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387 [TBL] [Abstract][Full Text] [Related]
26. Sex differences in coronary atherosclerosis progression and major adverse cardiac events in patients with suspected coronary artery disease. Gu H; Gao Y; Wang H; Hou Z; Han L; Wang X; Lu B J Cardiovasc Comput Tomogr; 2017; 11(5):367-372. PubMed ID: 28754436 [TBL] [Abstract][Full Text] [Related]
27. Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression. Sanidas EA; Mintz GS; Maehara A; Cristea E; Wennerblom B; Iñiguez A; Fajadet J; Fahy M; Dressler O; Weisz G; Templin B; Zhang Z; Lansky AJ; de Bruyne B; Serruys P; Stone GW JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S95-S105. PubMed ID: 22421236 [TBL] [Abstract][Full Text] [Related]
28. Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial. Tardif JC; Grégoire J; Lespérance J; Lambert J; L'Allier PL; Rodés J; Anderson T; Blue JW; Imus J; Heinonen T Am Heart J; 2002 Oct; 144(4):589-96. PubMed ID: 12360153 [TBL] [Abstract][Full Text] [Related]
29. Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery. Cavalcante R; Sotomi Y; Zeng Y; Lee CW; Ahn JM; Collet C; Tenekecioglu E; Suwannasom P; Onuma Y; Park SJ; Serruys PW Heart; 2017 Mar; 103(6):428-433. PubMed ID: 27651390 [TBL] [Abstract][Full Text] [Related]
36. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease. Langtry HD; Spencer CM Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871 [TBL] [Abstract][Full Text] [Related]
37. Association of progression or regression of coronary artery atherosclerosis with long-term prognosis. Ndrepepa G; Iijima R; Kufner S; Braun S; Cassese S; Byrne RA; Sorges J; Schulz-Schüpke S; Hoppmann P; Fussaro M; Laugwitz KL; Schunkert H; Kastrati A Am Heart J; 2016 Jul; 177():9-16. PubMed ID: 27297844 [TBL] [Abstract][Full Text] [Related]
38. Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study). Rodriguez-Granillo GA; Vos J; Bruining N; Garcia-Garcia HM; de Winter S; Ligthart JM; Deckers JW; Bertrand M; Simoons ML; Ferrari R; Fox KM; Remme W; De Feyter PJ; Am J Cardiol; 2007 Jul; 100(2):159-63. PubMed ID: 17631061 [TBL] [Abstract][Full Text] [Related]
39. Progression of coronary artery atherosclerosis after acute myocardial infarction: an angiographic study. Hawranek M; Gasior M; Gierlotka M; Wilczek K; Lekston A; Szygula-Jurkiewicz B; Spatuszko A; Polonski L J Invasive Cardiol; 2010 May; 22(5):209-15. PubMed ID: 20440036 [TBL] [Abstract][Full Text] [Related]
40. Effects of long term cholesterol lowering on coronary atherosclerosis in patient risk factor subgroups: the Simvastatin/enalapril Coronary Atherosclerosis Trial (SCAT). Burton JR; Teo KK; Buller CE; Plante S; Catellier D; Tymchak W; Taylor D; Dzavik V; Montague TJ; Can J Cardiol; 2003 Apr; 19(5):487-91. PubMed ID: 12717482 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]